NEW YORK — ProciseDx said on Tuesday that it has received CE marking for its Procise FCP point-of-care test for inflammatory bowel disease.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.